MeCo Diagnostics

Low cost drug repurposing for cancer

  • Stage Product In Development
  • Industry Biotechnology
  • Location San Diego, CA, USA
  • Currency USD
  • Founded March 2022
  • Employees 6
  • Incorporation Type C-corp
  • Website

Company Summary

MeCo Diagnostics is a venture-backed startup developing predictive biomarkers for breast cancer and prostate cancer that harness a low-toxicity, generic-emergent, FDA-approved drug to prevent metastasis. Our team has 60+ years of leadership experience commercializing laboratory-developed tests/in vitro diagnostics, along with a stellar publication record. We will seek revenue sharing with an established clinical genomics services provider.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free